Page last updated: 2024-08-21

c.i. 42510 and Lupus Nephritis

c.i. 42510 has been researched along with Lupus Nephritis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dai, C; Fu, SM; Gaskin, F; Huang, Y; Wang, H; Wang, S; Yang, N; Zhang, H; Zhao, J	1

Other Studies

1 other study(ies) available for c.i. 42510 and Lupus Nephritis

Article	Year
P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3/ASC/caspase 1 pathway. Arthritis and rheumatism, 2013, Volume: 65, Issue:12 Topics: Animals; Apoptosis Regulatory Proteins; CARD Signaling Adaptor Proteins; Carrier Proteins; Caspase 1; Cytoskeletal Proteins; Female; Inflammasomes; Kidney; Longevity; Lupus Nephritis; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2X7; Rosaniline Dyes; Severity of Illness Index; Signal Transduction	2013

Article

Year

P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3/ASC/caspase 1 pathway.

Arthritis and rheumatism, 2013, Volume: 65, Issue:12

Topics: Animals; Apoptosis Regulatory Proteins; CARD Signaling Adaptor Proteins; Carrier Proteins; Caspase 1; Cytoskeletal Proteins; Female; Inflammasomes; Kidney; Longevity; Lupus Nephritis; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2X7; Rosaniline Dyes; Severity of Illness Index; Signal Transduction

2013